Last Updated:
NameDesignationAppointment DateStatus
Mysore Sreekantiah Shivani

Appointed as Director since June 2010

Director07-Jun-2010Current
Shravanabelagola Nanjundaiah Sreekantaiah

Appointed as Director since June 2010

Director07-Jun-2010Current
Umadevi Puttaswamygowda Daniharry

Appointed as Director since June 2019

Director14-Jun-2019Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Cito Remedies Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Cito Remedies Private Limited's leadership journey.

Loading...
Contact Details
  • Address 167/F 1, 2Nd Cross, Canara Bank Colony, Nagarabhavi, Bangalore South, Bangalore Karnataka, 560072, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 560072
  • Country India
  • Website -
Frequently Asked Questions
You can contact Cito Remedies Private Limited through their registered address at 167/F 1, 2Nd Cross, Canara Bank Colony, Nagarabhavi, Bangalore South, Bangalore Karnataka, 560072, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Cito Remedies Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MYSORE SREEKANTIAH SHIVANI
  • UMADEVI PUTTASWAMYGOWDA DANIHARRY
  • SHRAVANABELAGOLA NANJUNDAIAH SREEKANTAIAH
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available